药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Canrenone
Canrenone may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Isosorbide
Isosorbide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Canrenoic acid
Canrenoic acid may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Azosemide
Azosemide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Indisulam
Indisulam may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Ularitide
Ularitide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Piretanide
Piretanide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Theobromine
Theobromine may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Quinethazone
Quinethazone may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Mersalyl
Arsenic trioxide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Xipamide
Arsenic trioxide may increase the excretion rate of Xipamide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Muzolimine
Arsenic trioxide may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Cyclopenthiazide
Arsenic trioxide may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Tienilic acid
Arsenic trioxide may increase the excretion rate of Tienilic acid which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Polythiazide
Arsenic trioxide may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Diazoxide
Arsenic trioxide may increase the excretion rate of Diazoxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Trichlormethiazide
Arsenic trioxide may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Mebutizide
Mebutizide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Potassium citrate
Potassium citrate may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.
Tazarotene
Diclofenamide
Diclofenamide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.